key: cord-0910171-ff4z4z72
authors: Naemi, Fatmah M. A.; Al‐adwani, Shurooq; Al‐khatabi, Heba; Al‐nazawi, Ashwaq
title: Association between the HLA genotype and the severity of COVID‐19 infection among South Asians
date: 2021-04-23
journal: J Med Virol
DOI: 10.1002/jmv.27003
sha: 2a1db75478f0c6ac21fdc6f71afe68f7f4d3a7fc
doc_id: 910171
cord_uid: ff4z4z72

Regional variations are found in the incidence and severity of the COVID‐19 infection. Human leukocyte antigen (HLA) polymorphism is one of the genetic factors that might have an impact on the outcome of the disease. This study explored the association between the HLA genotype and the severity of COVID‐19 among patients from South Asia. Blood samples from 95 Asians (Bangladeshis, Indians, and Pakistanis) with COVID‐19 were collected. The patients were divided according to the severity of their infection: mild (N = 64), severe (N = 31), and fatal (N = 20). DNA was extracted from all samples, and HLA genotyping was performed for both class I (A, B, and C) and class II (DRB1, DQA1, and DQB1) using the PCR‐rSSO (polymerase chain reaction–reverse sequence‐specific oligonucleotide) molecular method. The frequency of HLA‐B*51 was significantly higher among patients in the fatal group than among those in the mild infection group (15% vs. 4.7%, p = 0.027). Additionally, the frequency of HLA‐B*35 was significantly higher in the mild infection group than in the fatal group (21.1% vs. 7.5%, p = 0.050 [a borderline p‐value]). In terms of HLA class II, DRB1*13 was significantly observed in the fatal group than in the mild infection group (17.5% vs. 11.3%, p = 0.049). However, the p‐value for all alleles became insignificant after a statistical correction for the p‐values (p(c) = 0.216, p(c) = 0.4, and p(c) = 0.49, respectively). Compared with all published data, this study highlights that the association between the HLA system and the COVID‐19 outcome might be ethnic‐dependent. Genetic variation between populations must be examined on a wider scale to assess infection prognosis and vaccine effectiveness.

By January 2021, the positive cases of COVID-19 reported in more than 200 countries have exceeded 90 million in total, with more than 2 million deaths (https://covid19.who.int/table). The lack of understanding about the exact mechanism of the virus transmission increases the burden to control the spread of the infection between individuals. However, differences in the number of confirmed cases between countries and even between areas in the same country have been observed. 1 While the United States reported more than 23 million cases by January 2021, the confirmed cases in other areas have not exceeded half a million (https://covid19.who.int/table).

Additionally, the severity and fatality of the infection vary between populations, with a 2.6% fatality rate in some areas. 2 The severity of the infection ranges from being asymptomatic to developing into a fatal acute respiratory syndrome. 3, 4 South Asian countries, such as India, are the second most affected area worldwide, with more than 10 million cases and a mortality rate of around 1.3%, as reported in January 2021. Other South Asian countries, such as Pakistan and Bangladesh, reported cases exceeding 500 thousand each, with a mortality rate of around 0.4% (https://covid19.who.int/table). The rapid spread of the virus in this region can be attributed to the poor hygiene precautions and a large number of individuals in contact daily. 5 However, other factors, such as genetic variations, can also have an impact on virus transmission and infection severity. 6, 7 Previous studies reported an ethnic variation in the susceptibility to viruses and their severity. [8] [9] [10] This can be linked to the variations in the human leukocyte antigen (HLA), the highly polymorphic gene cluster in the human genome. Each HLA allele codes a specific HLA protein with a unique peptide-binding groove. Upon the virus' entry through mucous membranes, it will be randomly degraded into short peptides to be uploaded into a peptide-binding groove of the HLA molecules and will then be presented to the cell surface. 11 T lymphocytes will recognize the viral peptide presented by self-HLA molecules to elicit an antiviral immune response for virus eradication. The set of HLA alleles inherited by an individual will determine the immune responses to viruses according to the selected peptides that can bind to the peptide-binding groove. 12 HLA class I (A, B, and C) and class II (DRB1, DQA1, and DQB1) alleles have been shown to be associated with the susceptibility to and severity of various infectious diseases. [13] [14] [15] [16] In terms of COVID-19, studies from different populations showed an association between various HLA alleles and the susceptibility to or severity of the disease. [17] [18] [19] A recent study from Italy showed an increase in the frequency of B*27:07, DRB1*15:01, and DQB1*06:02 among severe COVID-19 patients in a cohort of 99 Italians. 18 However, another study from Sardinia in Italy showed a higher frequency of different allele, HLA-DRB1*08:01, among COVID-19

hospitalized patients compared to control. 20 A study from Spain, on the other hand, showed the relevance of HLA-A*11, C*01, and DQB1*04 to infection-related mortality in a cohort of 72 severe patients. 21 Additionally, epidemiological and bioinformatics studies from different groups reported different HLA alleles as either protective against or susceptible to infection. 19, 22, 23 The discrepancies between the studies can be attributed to the study design and the sample size, as well as ethnicity variations. Therefore, it is essential to study the association between HLA genotypes and COVID-19 in different populations worldwide.

In this study, the effect of HLA polymorphism on the severity of COVID-19 among South Asians was assessed and compared to the published data from other countries. This will help in finding the HLA marker related to the severity and fatality of COVID-19, which can be used to identify high-risk individuals. Studying such an association will also have an impact on vaccine innovation and assessing vaccine effectiveness. In Saudi Arabia, several positive cases of COVID-19

reported among non-Saudis reached more than 35% of all cases, adding more pressure on healthcare services. 24 Therefore, it was interesting to study the association between the HLA system and the severity of COVID-19 in the non-Saudi population. Patients from South Asia were selected due to the increased number of cases in the region compared to others, rendering them a good model to assess this association. To our knowledge, this is the first study on the association between HLA and COVID-19's severity in those populations.

This study was conducted after obtaining an approval from the Re- 

Blood samples were collected from all patients during their admission. The samples were collected in EDTA tubes for genomic DNA extraction. DNA was extracted using an automated closed system, the EZ1 Advanced XL instrument (Qiagen) located at King Fahd Research Center, King Abdulaziz University. DNA purities and concentrations were assessed using a NanoDrop spectrophotometer (Thermo Fisher Scientific). DNA purity was assessed, and samples with a DNA concentration higher than 1.8 for a 260/280 ratio were used for the HLA genotyping.

HLA genotyping was performed using molecular methods coupled with a multiplex solid-phase analysis, the PCR-rSSO (polymerase chain reaction-reverse sequence-specific oligonucleotide) method. DNA concentrations were adjusted to 20 ng/µl with molecular grade water for the HLA genotyping molecular assay. The test was performed using LABType SSO kits for each locus HLA-A, -B, -C, -DRB1, and -DQA1/B1 following company instructions (One Lambda). Briefly, genomic DNA was amplified NAEMI ET AL. 

The allele frequency in the cohort was assessed for the Hardy-Weinberg equilibrium using Guo and Thompson's method as a part of Python for Population Genomics, PyPop. 26 Mean and standard deviation were used to describe continuous variables, such as age, while frequency and percentage were used to describe categorical variables.

For small frequencies, the Χ 2 test or Fisher's exact test was applied to investigate the association between two categorical variables, whereas one-way analysis of variance (ANOVA) was used to compare the three groups. Statistical significance was determined at a p-value of 0.05. The allele frequency (F%) was determined as a percentage calculated by dividing the absolute count of each allele by the total number of alleles in each group. Statistical analyses were performed using SPSS (Statistical Package for the Social Sciences) software version 26. The

Bonferroni correction was applied to the p-value in that it was multiplied with the allele frequencies of >5% for each HLA locus.

In this study, the association between the HLA genotype and the dead-infected patients in the frequency of this allele (11.3% vs.

17.5%, p = 0.347, respectively).

Regarding the HLA-DQA1 genotype, the most common allele was DQA1*01 with 50% frequency in the subjects with mild infection and 65% frequency in both the ICU-admitted subjects and in the fatal cases. No statistically significant difference was found between the three groups in terms of the frequency of the HLA-DQA1 genotype alleles, as illustrated in Table 6 . In terms of the HLA-DQB1 genotype, the most common allele was DQB1*06 (29.7%) in the mildly infected patients while the most common allele in the ICU and in the fatal group patients was DQB1*05 with allele frequency 37.1% versus 37.5, respectively. No statistically significant difference was found between the compared groups in terms of the frequency of the HLA-DQB1 genotype alleles, as shown in Table 7 .

With the increased number of cases of COVID-19 worldwide, a remarkable increase in confirmed cases was obvious in some popula- genotype. 30 The antigen is also common in some populations in Pakistan but is less common in Bangladesh. 31 

Ethnicity and COVID-19: an urgent public health research priority

Mortality in COVID-19 disease patients: correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Covid-19: risk factors for severe disease and death

The rise and impact of COVID-19 in India

Human genetic determinants of viral diseases

Footprint of the COVID-19 pandemic in India: a study of immune landscape and other factors shielding mortality

Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire

Major histocompatibility complex genomics and human disease

Major Histocompatibility Complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation

HLA variation and disease

HLA and infectious diseases

A review of HLA allele and SNP associations with highly prevalent infectious diseases in human populations

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus

Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)

HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients

Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: a pilot study in a cohort of Covid-19 Spanish patients

Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course

HLA genetic polymorphisms and prognosis of patients with COVID-19

Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19

Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2

Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies

HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19

Activation of CD8 T lymphocytes during viral infections

Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India

Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP

HLA-A, -B and -DRB1 allele frequencies in the Bangladeshi population

Molecular analysis of human leukocyte antigen class I and class II allele frequencies and haplotype distribution in Pakistani population

Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen

Polymorphism of HLA class I and class II alleles in influenza A(H1N1)pdm09 virus infected population of Assam, Northeast India

Genetic contribution of MHC class II genes in susceptibility to West Nile virus infection

The authors would like to thank the Ministry of Health's Science and Technology Unit in the Kingdom of Saudi Arabia for their assistance.This study was kindly supported by King Abdulaziz City for Science and Technology (KACST) through Grant number 5-20-01-502-0009 via the Fast Track Funding Path for COVID-19.

The authors declare that there are no conflict of interests. Ashwaq Al-nazawi http://orcid.org/0000-0001-9528-1893